Clinical and dermoscopic features associated with lichen planus-like keratoses that undergo skin biopsy: A single-center, observational study.


Journal

The Australasian journal of dermatology
ISSN: 1440-0960
Titre abrégé: Australas J Dermatol
Pays: Australia
ID NLM: 0135232

Informations de publication

Date de publication:
May 2019
Historique:
received: 24 09 2018
accepted: 17 10 2018
pubmed: 20 11 2018
medline: 18 12 2019
entrez: 20 11 2018
Statut: ppublish

Résumé

Lichen planus-like keratoses (LPLK) are benign skin lesions that can mimic malignancy; the clinical and dermoscopic features distinguishing lichen planus-like keratoses from skin tumors have not been extensively studied. The objective of this study was to identify dermoscopic features that may prevent unnecessary biopsies of lichen planus-like keratoses. Retrospective, single-center, observational study of biopsied skin lesions at a tertiary center. We compared 355 lichen planus-like keratoses to 118 non-lichen planus-like keratoses lesions with lichen planus-like keratosis in the differential diagnosis biopsied from August 1, 2015, to December 31, 2016. The investigators were blinded to the diagnosis of the lesions. Lichen planus-like keratoses were most frequently non-pigmented (61.7%), truncal (52.1%), and on sun-damaged skin (69.6%); the majority occurred in Whites (95.5%) and females (62.8%). Dermoscopically, lichen planus-like keratoses were more likely than non-lichen planus-like keratoses to have scale (42.5% vs 31.4%, P = 0.03) and orange colour (8.2% vs 0.9%, P = 0.01). Among lesions with peppering (n = 76; 63 lichen planus-like keratoses and 13 non-lichen planus-like keratoses), coarse ± fine peppering (73% vs 38.5%, P = 0.02) and peppering as the only feature (34.9% vs 0%, P = 0.01) were associated with lichen planus-like keratoses. Lichen planus-like keratoses can be challenging to distinguish from benign and malignant skin tumors. The presence of dermoscopic scale and orange colour may aid in the recognition of lichen planus-like keratosis. Coarse peppering and the presence of peppering as the only dermoscopic feature may further aid the identification of pigmented lichen planus-like keratoses.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
Lichen planus-like keratoses (LPLK) are benign skin lesions that can mimic malignancy; the clinical and dermoscopic features distinguishing lichen planus-like keratoses from skin tumors have not been extensively studied. The objective of this study was to identify dermoscopic features that may prevent unnecessary biopsies of lichen planus-like keratoses.
METHODS METHODS
Retrospective, single-center, observational study of biopsied skin lesions at a tertiary center. We compared 355 lichen planus-like keratoses to 118 non-lichen planus-like keratoses lesions with lichen planus-like keratosis in the differential diagnosis biopsied from August 1, 2015, to December 31, 2016. The investigators were blinded to the diagnosis of the lesions.
RESULTS RESULTS
Lichen planus-like keratoses were most frequently non-pigmented (61.7%), truncal (52.1%), and on sun-damaged skin (69.6%); the majority occurred in Whites (95.5%) and females (62.8%). Dermoscopically, lichen planus-like keratoses were more likely than non-lichen planus-like keratoses to have scale (42.5% vs 31.4%, P = 0.03) and orange colour (8.2% vs 0.9%, P = 0.01). Among lesions with peppering (n = 76; 63 lichen planus-like keratoses and 13 non-lichen planus-like keratoses), coarse ± fine peppering (73% vs 38.5%, P = 0.02) and peppering as the only feature (34.9% vs 0%, P = 0.01) were associated with lichen planus-like keratoses.
CONCLUSIONS CONCLUSIONS
Lichen planus-like keratoses can be challenging to distinguish from benign and malignant skin tumors. The presence of dermoscopic scale and orange colour may aid in the recognition of lichen planus-like keratosis. Coarse peppering and the presence of peppering as the only dermoscopic feature may further aid the identification of pigmented lichen planus-like keratoses.

Identifiants

pubmed: 30450536
doi: 10.1111/ajd.12955
pmc: PMC6520177
mid: NIHMS994186
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e119-e126

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIH/NCI Cancer Center
ID : P30 CA008748

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 The Australasian College of Dermatologists.

Références

J Invest Dermatol. 1975 Nov;65(5):429-33
pubmed: 127813
Am J Dermatopathol. 2005 Oct;27(5):387-92
pubmed: 16148406
Arch Dermatol. 2006 Mar;142(3):410
pubmed: 16549732
Br J Dermatol. 2007 Aug;157(2):266-72
pubmed: 17553042
Dermatol Surg. 2007 Jul;33(7):854-6
pubmed: 17598855
Dermatology. 2007;215(3):256-9
pubmed: 17823526
J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1392-7
pubmed: 17958847
Br J Dermatol. 2009 Mar;160(3):546-51
pubmed: 19076977
Dermatology. 2010;220(2):103-9
pubmed: 19996577
J Am Acad Dermatol. 2011 Jun;64(6):1068-73
pubmed: 21440329
J Eur Acad Dermatol Venereol. 2012 May;26(5):578-90
pubmed: 21605173
J Am Acad Dermatol. 2011 Sep;65(3):e85-e87
pubmed: 21839306
Arch Dermatol. 2011 Dec;147(12):1468
pubmed: 22184782
Br J Dermatol. 2012 Apr;166(4):784-8
pubmed: 22188534
Dermatol Pract Concept. 2012 Apr 30;2(2):202a08
pubmed: 23785596
J Am Acad Dermatol. 2015 Jan;72(1 Suppl):S27-9
pubmed: 25500032
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2317-25
pubmed: 26369295
J Am Acad Dermatol. 2016 Jun;74(6):1093-106
pubmed: 26896294
Dermatol Pract Concept. 2016 Apr 30;6(2):29-35
pubmed: 27222769
Dermatol Pract Concept. 2016 Oct 31;6(4):13-18
pubmed: 27867740
Clin Exp Dermatol. 2017 Aug;42(6):663-666
pubmed: 28636260
Acta Derm Venereol. 2017 Nov 15;97(10):1219-1224
pubmed: 28761960
Dermatol Pract Concept. 2018 Jan 31;8(1):51-53
pubmed: 29445576
J Cutan Pathol. 1986 Aug;13(4):308-11
pubmed: 3771875
Am J Clin Pathol. 1985 Apr;83(4):439-43
pubmed: 3984937
J Am Acad Dermatol. 1984 Oct;11(4 Pt 1):635-8
pubmed: 6490989
Arch Dermatol. 1982 Feb;118(2):93-6
pubmed: 7059225

Auteurs

Konstantinos Liopyris (K)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Department of Dermatology, A. Syggros Hospital, University of Athens, Athens, Greece.

Cristian Navarrete-Dechent (C)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Department of Dermatology, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Stephen W Dusza (SW)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Ashfaq A Marghoob (AA)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Liang Deng (L)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Barbara B Wilson (BB)

Department of Dermatology, University of Virginia, Charlottesville, Virginia, USA.

Michael A Marchetti (MA)

Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH